246 / DOI: 10.3332/ecancer.2012.246ecancer 6
Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage nonsmall cell lung carcinomas with 80% accuracy.
21 Nov 2013 / DOI: 10.3332/ecancer.2013.375Published:
19 Nov 2013 / DOI: 10.3332/ecancer.2013.374Published:
12 Nov 2013 / DOI: 10.3332/ecancer.2013.372Published:
17 Oct 2013 / DOI: 10.3332/ecancer.2013.364Published:
10 Oct 2013 / DOI: 10.3332/ecancer.2013.361Published: